perifosine has been researched along with Soft Tissue Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, HH; Erlichman, C; Ettinger, DS; Fracasso, PM; Mahoney, MR; Maples, WJ; Okuno, SH; Traynor, AM | 1 |
1 trial(s) available for perifosine and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phosphorylcholine; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome | 2006 |